Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xylem Inc. Director's Dealing 2011

Nov 3, 2011

30109_dirs_2011-11-03_d8d2a979-5d08-45a0-ac55-c1d2a3bfa65c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01

Reporting Person: Speetzen Michael T (Chief Financial Officer & SVP)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-01 Common Stock A 13285 $0.00 Acquired 26008 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-01 Employee Stock Option (Right to Buy) $18.63 A 8772 Acquired 2016-03-05 Common Stock (8772) Direct
2011-11-01 Employee Stock Option (Right to Buy) $30.03 A 12709 Acquired 2020-03-05 Common Stock (12709) Direct
2011-11-01 Employee Stock Option (Right to Buy) $32.38 A 13608 Acquired 2021-03-03 Common Stock (13608) Direct

Footnotes

F1: The total amount of securities beneficially owned following the reported transactions includes securities that were received in connection with the spin-off of Xylem Inc. from ITT Corporation in a transaction that was exempt from reporting under Rule 16a-9 under the Securities Exchange Act of 1934.

F2: 2,880 options are vested and exercisable and the remaining 5,892 options will vest on March 5, 2012.

F3: 4,237 options are vested and exercisable and the remainder will vest in two equal annual installments beginning on March 5, 2012.

F4: These options vest in three equal annual installments beginning on March 3, 2012.